Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Zolbetuximab regimen extends PFS in metastatic gastric, gastroesophageal junction cancers
The addition of zolbetuximab to chemotherapy improved PFS among certain patients with gastric or gastroesophageal junction cancers, according to the agent’s manufacturer.
Follow-up surveillance within 5 years may detect post-colonoscopy CRC
CHARLOTTE, N.C. — Recommended surveillance interval was the most important modifiable risk factor for post-colonoscopy colorectal cancer at 3 years, according to research presented at the ACG Annual Scientific Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Onivyde regimen extends OS in metastatic pancreatic ductal adenocarcinoma
An irinotecan liposome injection regimen improved OS compared with standard chemotherapy among untreated patients with metastatic pancreatic ductal adenocarcinoma, according to the agent’s manufacturer.
Improved culturally competent care may boost early detection in ‘late-stage HCC hotspots’
WASHINGTON — Increased culturally competent care and improved access to medical transport may improve early detection of hepatocellular carcinoma in patients who live in late-stage hotspots, according to researchers at The Liver Meeting.
‘Significant’ racial, ethnic disparities exist in curative treatment for early-stage HCC
WASHINGTON — Fewer Black and Hispanic patients received curative treatment for early-stage hepatocellular carcinoma compared with white patients, according to research presented at The Liver Meeting.
MMaT-3 policy decreases survival, increases recurrence after transplant in HCC patients
WASHINGTON — The MELD score at transplant minus three points policy led to poor survival and recurrence outcomes after liver transplantation among patients with hepatocellular carcinoma, according to research at The Liver Meeting.
FDA grants orphan drug designation to OTX-2002 for hepatocellular carcinoma
The FDA granted orphan drug designation to OTX-2002 for the treatment of hepatocellular carcinoma, according to the agent’s manufacturer.
Endoscopic ultrasound-guided radiofrequency ablation extends survival in PDAC
CHARLOTTE, N.C. — Endoscopic ultrasound-guided radiofrequency ablation, alone or combined with chemotherapy, improved survival and progression-free survival among a small subset of patients with primary pancreatic ductal adenocarcinoma.
Achalasia associated with five-fold higher risk for esophageal cancer
CHARLOTTE, N.C. — Achalasia was associated with an increased risk for esophageal cancer among a cohort of veterans, suggesting the need for increased endoscopic surveillance, according to a presenter at the ACG Annual Scientific Meeting.
High inflammatory markers tied to poor prognosis, survival in patients with gastric cancer
CHARLOTTE, N.C. — Elevated baseline neutrophil-to-lymphocyte ratio was associated with distant metastases and poor survival in patients with gastric cancer, according to a presenter at the ACG Annual Scientific Meeting.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read